The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases, which could be a boon for health tech companies that have struggled with reimbursement.
Explore the new AI model that links genetic mutations to disease outcomes, revolutionising genetic diagnosis and treatment.
More than 300 people across academia and industry spilled into an auditorium to attend a BoltzGen seminar on Thursday, Oct. 30, hosted by the Abdul Latif Jameel Clinic for Machine Learning in Health ...
Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...
Generative artificial intelligence is moving from the margins of pharma into the center of how new medicines are imagined, built, and tested. Instead of tweaking existing compounds, these models can ...